CORT

#3769
Corcept Therapeutics Incorporated - Common Stock
0.6 9 USD
-98.98%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
0.69
0.69
년간 변동
0.69
89.00
일일 변동
-98.98%
월간 변동
-98.52%
6달 변화
-99.11%
년간 변동율
-99.05%
이전 종가
68.3 8
Open
0.6 9
저가
0.6 9
High
0.6 9
양
220
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 74.6 M
  • Employee 730
  • Founded 1998
  • CEO N/A
  • Website www.corcept.com
  • Headquarter Delaware, United States
  • FIGI BBG000BKJG33
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
42.44
주가매출액비율
5.48

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

뉴스